4.6 Review

Neuroplastin in Neuropsychiatric Diseases

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

N-Cadherin Regulates GluA1-Mediated Depressive-Like Behavior in Adolescent Female Rat Offspring following Prenatal Stress

Shuya Shao et al.

Summary: The study found that prenatal stress can lead to gender-dependent depressive-like behavior in adolescent female rats, with the neuro-physiological mechanisms primarily involving the expression of the N-cadherin-GluA1 pathway. By administering appropriate treatments, depressive-like behavior in adolescent female offspring following PS can be improved.

NEUROENDOCRINOLOGY (2022)

Review Pharmacology & Pharmacy

Novel treatments for autism spectrum disorder based on genomics and systems biology

Danielle Baribeau et al.

Summary: Autism spectrum disorder is a neurodevelopmental disorder with no known pharmacologic treatments for core symptoms. However, numerous clinical trials are investigating novel and existing agents for their impact on symptoms. Alterations in transcriptional regulation, chromatin remodeling, synaptic transmission, neuropeptide signaling, and immunological mechanisms may contribute to the development of ASD. Further collaboration and innovation in outcome measurement, biomarker research, genomics, and subgroup identification are necessary for identifying effective pharmacologic treatments.

PHARMACOLOGY & THERAPEUTICS (2022)

Review Neurosciences

Looking for Novelty in an Old Receptor: Recent Advances Toward Our Understanding of GABAARs and Their Implications in Receptor Pharmacology

David Castellano et al.

Summary: GABA(A) receptors play a crucial role in neurological and neuropsychiatric disorders, and current pharmacological interventions targeting these receptors have limitations in terms of selectivity and side effects. The development of more selective drugs and exploration of next-generation drugs targeting accessory proteins associated with the receptors are necessary in order to improve treatment outcomes.

FRONTIERS IN NEUROSCIENCE (2021)

Review Neurosciences

GluA1-homomeric AMPA receptor in synaptic plasticity and neurological diseases

Yuan Ge et al.

Summary: Synaptic transmission is crucial for brain function, with AMPARs playing a key role in regulating the strength of synaptic transmission. Rapid trafficking of AMPARs is important for synaptic plasticity and learning, but defects in this process can lead to certain neurological disorders. Studies over the past 30 years have provided detailed insights into AMPAR trafficking mechanisms, especially highlighting the involvement of GluA1-homomeric receptors in various types of synaptic plasticity.

NEUROPHARMACOLOGY (2021)

Article Multidisciplinary Sciences

The amino-terminal domain of GluA1 mediates LTP maintenance via interaction with neuroplastin-65

Chao-Hua Jiang et al.

Summary: Long-term potentiation (LTP) is a crucial cellular mechanism for learning and memory, with the amino-terminal domain (ATD) of GluA1 interacting with neuroplastin-65 (Np65) playing a key role in anchoring AMPARs at the postsynaptic membrane during LTP.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Anatomy & Morphology

Neuroplastin expression is essential for hearing and hair cell PMCA expression

Xiao Lin et al.

Summary: The study found that the absence of neuroplastin in mice leads to hearing impairment, accompanied by degeneration of hair cells and spiral ganglion cells, as well as reduced baseline blood flow in the auditory cortex. Neuroplastin is required for the expression of PMCA 2 in outer hair cells, suggesting that altered Ca2+ homeostasis underlies the observed hearing impairments and hair cell degeneration.

BRAIN STRUCTURE & FUNCTION (2021)

Article Neurosciences

αCaMKII in the lateral amygdala mediates PTSD-Like behaviors and NMDAR-Dependent LTD

Shuming An et al.

Summary: The research discovered that PTSD susceptible mice exhibited significant up-regulation of alpha CaMKII in the lateral amygdala, leading to PTSD-like behaviors. Inhibiting alpha CaMKII levels completely rescued these behaviors and related impairments, suggesting that alpha CaMKII may be a potential molecular determinant of PTSD.

NEUROBIOLOGY OF STRESS (2021)

Article Pharmacology & Pharmacy

Aducanumab: First Approval

Sohita Dhillon

Summary: Aducanumab is a monoclonal antibody developed for the treatment of Alzheimer's disease, targeting aggregated forms of amyloid beta. It has received approval in the USA for use in patients with mild cognitive impairment or mild dementia. Ongoing studies are evaluating its safety and efficacy in patients with early Alzheimer's disease.

DRUGS (2021)

Article Pharmacology & Pharmacy

Olanzapine/Samidorphan: First Approval

Julia Paik

Summary: Samidorphan, developed by Alkermes, is an opioid receptor antagonist co-formulated with olanzapine into a single-dose oral tablet to reduce weight gain risk while maintaining the therapeutic effect of olanzapine. Recently approved in the USA for the treatment of schizophrenia and bipolar I disorder, olanzapine/samidorphan represents a milestone in the development of samidorphan.

DRUGS (2021)

Article Neurosciences

Cortical Networks of Creative Ability Trace Gene Expression Profiles of Synaptic Plasticity in the Human Brain

William Orwig et al.

Summary: By combining functional neuroimaging data with gene expression information, researchers have identified strong spatial correlations between connectivity maps and sets of genes devoted to synaptic assembly and signaling, linking cognitive flexibility to neural plasticity in the human brain.

FRONTIERS IN HUMAN NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity

Maria Berrocal et al.

Summary: The study focuses on sorcin as a potential regulator of PMCA and an antagonist of A beta and tau toxicity. Results demonstrate that sorcin acts as an activator of PMCA, counteracting the inhibitory effects of A beta and tau on the pump, and interacting with them to neutralize their neurotoxicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Genetic manipulations of AMPA glutamate receptors in hippocampal synaptic plasticity

Radu Gugustea et al.

Summary: AMPARs are crucial for fast excitatory synaptic transmission and key mechanisms of learning and memory. Studies show multiple forms of LTP and LTD at the hippocampal CA1 synapse regulated by different AMPAR subunits and induction protocols, emphasizing the necessity to understand the mechanisms of each form and their impact on memory and brain disorders.

NEUROPHARMACOLOGY (2021)

Review Psychiatry

Neuroplastin in human cognition: review of literature and future perspectives

Katarina Ilic et al.

Summary: Neuroplastin, a synaptic glycoprotein, plays a crucial role in synaptic plasticity, cognition, and memory formation. It is involved in regulating calcium homeostasis and is associated with genetic traits like cortical thickness, intelligence, schizophrenia, and autism in humans. Future studies may shed more light on its role as a key molecule in human cognition.

TRANSLATIONAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Understanding the genetics of neuropsychiatric disorders: the potential role of genomic regulatory blocks

Anja Baresic et al.

MOLECULAR PSYCHIATRY (2020)

Article Genetics & Heredity

Refining critical regions in 15q24 microdeletion syndrome pertaining to autism

Yi Liu et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2020)

Article Cell Biology

The Interaction of TRAF6 With Neuroplastin Promotes Spinogenesis During Early Neuronal Development

Sampath Kumar Vemula et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Multidisciplinary Sciences

Neuroplastin Modulates Anti-inflammatory Effects of MANF

Takuya Yagi et al.

ISCIENCE (2020)

Review Clinical Neurology

A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment

Brati Das et al.

CNS DRUGS (2019)

Article Biochemistry & Molecular Biology

Neuroplastin- mediates S100A8/A9-induced lung cancer disseminative progression

I. Wayan Sumardika et al.

MOLECULAR CARCINOGENESIS (2019)

Article Biochemistry & Molecular Biology

Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function

Maria Berrocal et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Neurosciences

New insights on synaptic dysfunction in neuropsychiatric disorders

Gladys Lima Caldeira et al.

CURRENT OPINION IN NEUROBIOLOGY (2019)

Article Genetics & Heredity

Target Genes of Autism Risk Loci in Brain Frontal Cortex

Yan Sun et al.

FRONTIERS IN GENETICS (2019)

Review Chemistry, Multidisciplinary

Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety

Xia Chen et al.

ACTA PHARMACOLOGICA SINICA (2019)

Article Cell Biology

Hippocampal expression of cell-adhesion glycoprotein neuroplastin is altered in Alzheimer's disease

Katarina Ilic et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Review Psychology, Developmental

The Economic Costs of Autism Spectrum Disorder: A Literature Review

Nicky Rogge et al.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2019)

Review Neurosciences

Roles of TRAF6 in Central Nervous System

Yang Dou et al.

CURRENT NEUROPHARMACOLOGY (2018)

Review Neurosciences

PMCA2 pump mutations and hereditary deafness

Mario Bortolozzi et al.

NEUROSCIENCE LETTERS (2018)

Article Psychiatry

(Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia

Allyson P. Mallya et al.

SCHIZOPHRENIA BULLETIN (2018)

Editorial Material Genetics & Heredity

Synaptic dysfunction in complex psychiatric disorders: from genetics to mechanisms

Xinyuan Wang et al.

GENOME MEDICINE (2018)

Article Multidisciplinary Sciences

Structure of a human synaptic GABAA receptor

Shaotong Zhu et al.

NATURE (2018)

Article Multidisciplinary Sciences

Structure of the human plasma membrane Ca2+-ATPase 1 in complex with its obligatory subunit neuroplastin

Deshun Gong et al.

NATURE COMMUNICATIONS (2018)

Review Clinical Neurology

BACE inhibitors in clinical development for the treatment of Alzheimer's disease

Francesco Panza et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)

Editorial Material Medicine, General & Internal

Why do so many clinical trials of therapies for Alzheimer's disease fail?

Roy M. Anderson et al.

LANCET (2017)

Article Multidisciplinary Sciences

A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation

Mark Korthals et al.

SCIENTIFIC REPORTS (2017)

Review Chemistry, Multidisciplinary

Amyloid beta: structure, biology and structure-based therapeutic development

Guo-fang Chen et al.

ACTA PHARMACOLOGICA SINICA (2017)

Article Neurosciences

Genetically Induced Retrograde Amnesia of Associative Memories After Neuroplastin Ablation

Soumee Bhattacharya et al.

BIOLOGICAL PSYCHIATRY (2017)

Article Biochemistry & Molecular Biology

Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?

Elena Popugaeva et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Dermatology

Identification of an S100A8 Receptor Neuroplastin-β and its Heterodimer Formation with EMMPRIN

Masakiyo Sakaguchi et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Article Behavioral Sciences

Neuroplastin 65 mediates cognitive functions via excitatory/inhibitory synapse imbalance and ERK signal pathway

Siyiti Amuti et al.

NEUROBIOLOGY OF LEARNING AND MEMORY (2016)

Article Multidisciplinary Sciences

Xkr8 phospholipid scrambling complex in apoptotic phosphatidylserine exposure

Jun Suzuki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Behavioral Sciences

Reduced Prepulse Inhibition as a Biomarker of Schizophrenia

Auxiliadora Mena et al.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2016)

Article Biochemistry & Molecular Biology

Inhibition of PMCA activity by tau as a function of aging and Alzheimer's neuropathology

Maria Berrocal et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)

Article Biochemistry & Molecular Biology

The plethora of PMCA isoforms: Alternative splicing and differential expression

Joachim Krebs

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)

Review Neurosciences

Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia

Guillermo Gonzalez-Burgos et al.

BIOLOGICAL PSYCHIATRY (2015)

Article Biochemistry & Molecular Biology

Structure of Excitatory Synapses and GABAA Receptor Localization at Inhibitory Synapses Are Regulated by Neuroplastin-65

Rodrigo Herrera-Molina et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Biochemistry & Molecular Biology

The Plasma Membrane Calcium Pump: New Ways to Look at an Old Enzyme

Raffaele Lopreiato et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Biochemistry & Molecular Biology

The Neuroplastin adhesion molecules: key regulators of neuronal plasticity and synaptic function

Philip W. Beesley et al.

JOURNAL OF NEUROCHEMISTRY (2014)

Article Multidisciplinary Sciences

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke et al.

NATURE (2014)

Meeting Abstract Economics

GLOBAL ECONOMIC BURDEN OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW

H. Y. Chong et al.

VALUE IN HEALTH (2014)

Review Biochemistry & Molecular Biology

Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders

Peter Penzes et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Article Clinical Neurology

Evaluation of the GABAergic nervous system in autistic brain: 123I-iomazenil SPECT study

Tatsuo Mori et al.

BRAIN & DEVELOPMENT (2012)

Review Neurosciences

Synaptopathies: diseases of the synaptome

Seth G. N. Grant

CURRENT OPINION IN NEUROBIOLOGY (2012)

Article Biochemistry & Molecular Biology

The Cell Adhesion Molecule Neuroplastin-65 Is a Novel Interaction Partner of γ-Aminobutyric Acid Type A Receptors

Isabella Sarto-Jackson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2

Michael J. Schmeisser et al.

NATURE (2012)

Review Neurosciences

Interneuron dysfunction in psychiatric disorders

Oscar Marin

NATURE REVIEWS NEUROSCIENCE (2012)

Article Clinical Neurology

Cost of disorders of the brain in Europe 2010

Anders Gustavsson et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)

Article Biochemistry & Molecular Biology

Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3

Xiaoming Wang et al.

HUMAN MOLECULAR GENETICS (2011)

Article Biochemistry & Molecular Biology

Neuroplastin-65 and a mimetic peptide derived from its homophilic binding site modulate neuritogenesis and neuronal plasticity

Sylwia Owczarek et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Pharmacology & Pharmacy

Pharmacological Study on Alzheimer's Drugs Targeting Calcium/Calmodulin-Dependent Protein Kinase II

Shigeki Moriguchi

JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)

Article Neurosciences

Deletion of the GluA1 AMPA receptor subunit alters the expression of short-term memory

David J. Sanderson et al.

LEARNING & MEMORY (2011)

Article Multidisciplinary Sciences

Shank3 mutant mice display autistic-like behaviours and striatal dysfunction

Joao Peca et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

Synaptopathy: dysfunction of synaptic function?

Nils Brose et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2010)

Review Neurosciences

Signaling mechanisms regulating synapse formation and function in mental retardation

Bernadett Boda et al.

CURRENT OPINION IN NEUROBIOLOGY (2010)

Article Biochemistry & Molecular Biology

Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor

Sylwia Owczarek et al.

FASEB JOURNAL (2010)

Article Multidisciplinary Sciences

Nuclear and Mitochondrial Genome Defects in Autisms

Moyra Smith et al.

YEAR IN HUMAN AND MEDICAL GENETICS 2009 (2009)

Article Oncology

Identification of novel tumor antigens with patient-derived immune-selected antibodies

Daniel Rodriguez-Pinto et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)

Article Multidisciplinary Sciences

Neuroligins and neurexins link synaptic function to cognitive disease

Thomas C. Sudhof

NATURE (2008)

Article Biochemistry & Molecular Biology

Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors

L. M. Wiedholz et al.

MOLECULAR PSYCHIATRY (2008)

Article Psychiatry

Neuregulin 1 genotype and schizophrenia

Marcus R. Munafo et al.

SCHIZOPHRENIA BULLETIN (2008)

Article Neurosciences

Searching for ways out of the autism maze: genetic, epigenetic and environmental clues

Antonio M. Persico et al.

TRENDS IN NEUROSCIENCES (2006)

Letter Biochemistry & Molecular Biology

Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients

J Yan et al.

MOLECULAR PSYCHIATRY (2005)

Article Neurosciences

Autism and abnormal development of brain connectivity

MK Belmonte et al.

JOURNAL OF NEUROSCIENCE (2004)

Article Medicine, General & Internal

Evidence of brain overgrowth in the first year of life in autism

E Courchesne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Biochemistry & Molecular Biology

A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function

AP Armstrong et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia

K Sakurai et al.

MOLECULAR PSYCHIATRY (2002)

Article Biochemistry & Molecular Biology

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

N Kobayashi et al.

EMBO JOURNAL (2001)

Article Multidisciplinary Sciences

The synaptic glycoprotein neuroplastin is involved in long-term potentiation at hippocampal CA1 synapses

KH Smalla et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)